| 000 | 01580 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514000445.0 | ||
| 264 | 0 | _c20010705 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0022-202X | ||
| 024 | 7 |
_a10.1046/j.1523-1747.2001.01306.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKakurai, M | |
| 245 | 0 | 0 |
_aVasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. _h[electronic resource] |
| 260 |
_bThe Journal of investigative dermatology _cMay 2001 |
||
| 300 |
_a743-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclic AMP _xbiosynthesis |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 |
_aFibroblasts _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratinocytes _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Vasoactive Intestinal Peptide _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Vasoactive Intestinal Polypeptide, Type I |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
| 700 | 1 | _aFujita, N | |
| 700 | 1 | _aMurata, S | |
| 700 | 1 | _aFurukawa, Y | |
| 700 | 1 | _aDemitsu, T | |
| 700 | 1 | _aNakagawa, H | |
| 773 | 0 |
_tThe Journal of investigative dermatology _gvol. 116 _gno. 5 _gp. 743-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1523-1747.2001.01306.x _zAvailable from publisher's website |
| 999 |
_c11281118 _d11281118 |
||